Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease

Inflammatory Bowel Diseases

Volumn 21, Issue 6, 2015, Pages 1321-1328

  Szigethy, Eva ^a   Youk, Ada O ^b   Gonzalez Heydrich, Joseph ^c   Bujoreanu, Simona I ^c   Weisz, John ^d   Fairclough, Diane ^e   Ducharme, Peter ^c   Jones, Neil ^a   Lotrich, Francis ^a   Keljo, David ^f   Srinath, Arvind ^f   Bousvaros, Athos ^c   Kupfer, David ^a   Demaso, David R ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD UNIVERSITY   (United States)

^e Food Science and Human Nutrition   (United States)

^f CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Crohn's disease; Depression; inflammation; inflammatory bowel disease; physical illness; psychotherapy; somatic depressive symptoms

Indexed keywords

ARTICLE; CHILDREN DEPRESSION RATING SCALE REVISED; COGNITIVE THERAPY; CONTROLLED STUDY; COPING BEHAVIOR; COUNSELING; CROHN DISEASE; DEPRESSION; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SECONDARY ANALYSIS; SINGLE BLIND PROCEDURE; ADAPTIVE BEHAVIOR; ADOLESCENT; CHILD; DEPRESSIVE DISORDER; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOTHERAPY; SEVERITY OF ILLNESS INDEX; SOCIAL SUPPORT;

CORTICOSTEROID;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; COGNITIVE THERAPY; CROHN DISEASE; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; SEVERITY OF ILLNESS INDEX; SOCIAL SUPPORT;

EID: 84929887288     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000358     Document Type: Article

References (55)

1. Bennett DS. Depression among children with chronic medical problems: a meta-analysis. J Pediatr Psychol. 1994;19:149-169.
2. Blackman JA, Conaway MR. Developmental, emotional and behavioral co-morbidities across the chronic health condition spectrum. J Pediatr Rehabil Med. 2013;6:63-71.
3. Verhoof E, Maurice-Stam H, Heymans H, et al. Health-related quality of life, anxiety and depression in young adults with disability benefits due to childhood-onset somatic conditions. Child Adolesc Psychiatry Ment Health. 2013;7:12.
4. Regueiro MD, Swoger JM. Clinical Challenges and Complications of IBD. Thorofare, NJ: SLACK Inc; 2013.
5. Michail S, Ramsy M, Soliman E. Advances in inflammatory bowel diseases in children. Minerva Pediatr. 2012;64:257-270.
6. Burke P, Meyer V, Kocoshis S, et al. Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis. J Am Acad Child Adolesc Psychiatry. 1989;28:948-951.
7. Szigethy E, Levy-Warren A, Whitton S, et al. Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatric Gastroenterology Nutrition. 2004;39:395-403.
8. Greenley RN, Hommel KA, Nebel J, et al. A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol. 2010;35:857-869.
9. Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology. 2013;144:36-49.
10. Gabbay V, Klein RG, Alonso CM, et al. Immune system dysregulation in adolescent major depressive disorder. J Affect Disord. 2009;115:177-182.
11. Mills NT, Scott JG, Wray NR, et al. Research review: the role of cytokines in depression in adolescents: a systematic review. J Child Psychol Psychiatry. 2013;54:816-835.
12. Hood KK, Lawrence JM, Anderson A, et al. Metabolic and inflammatory links to depression in youth with diabetes. Diabetes Care. 2012;35: 2443-2446.
13. Shanahan L, Copeland WE, Worthman CM, et al. Children with both asthma and depression are at risk for heightened inflammation. J Pediatr. 2013.
14. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun. 2007;21:153-160.
15. Biesmans S, Meert TF, Bouwknecht JA, et al. Systemic immune activation leads to neuroinflammation and sickness behavior in mice. Mediators Inflamm. 2013;2013:271359.
16. Capuron L, Gumnick JF, Musselman DL, et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology. 2002;26:643-652.
17. Tsuru S, Nomoto K, Taniguchi M, et al. Depression of protective mechanism during the early phase of a viral infection in tumor-bearing mice and prevention by PSK. Cancer Immunol Immunother. 1986;22:114-118.
18. Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn's disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatric Gastroenterology Nutrition. 2007;44:653-674.
19. Ponder A, Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol. 2013;5:237-247.
20. Szigethy E, Bujoreanu SI, Youk AO, et al. Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry. 2014;53:726-735.
21. Szigethy E, Whitton SW, Levy-Warren A, et al. Cognitive-behavioral therapy for depression in adolescents with inflammatory bowel disease: a pilot study. J Am Acad Child Adolesc Psychiatry. 2004;43:1469-1477.
22. Szigethy E, Kenney E, Carpenter J, et al. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry. 2007;46:1290-1298.
23. Mrakotsky C, Forbes PW, Bernstein JH, et al. Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease. J Int Neuropsychol Soc. 2013;19:96-109.
24. Kovacs M. The Children's Depression, Inventory (CDI). Psychopharmacol Bull. 1985;21:995-998.
25. Kaufman J, Birmaher B, Brent D, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980-988.
26. American Psychiatric A, American Psychiatric Association. Task Force on D-I. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
27. Poznanski EO, Mokros HB. Children's Depression Rating Scale, Revised (CDRS-R) Manual. Los Angeles, CA: Western Psychological Services; 1996.
28. Morrison KM, Goli A, Van Wagoner J, et al. Depressive symptoms in inner-city children with asthma. Prim Care Companion J Clin Psychiatry. 2002;4:174-177.
29. Harms HK, Blomer R, Bertele-Harms RM, et al. A paediatric Crohn's disease activity index (PCDAI). Is it useful? Study Group on Crohn's Disease in Children and Adolescents. Acta Paediatr Suppl. 1994;83:22-26.
30. Loonen HJ, Griffiths AM, Merkus MP, et al. A critical assessment of items on the Pediatric Crohn's Disease Activity Index. J Pediatric Gastroenterology Nutrition. 2003;36:90-95.
31. Turner D, Griffiths AM, Walters TD, et al. Appraisal of the pediatric Crohn's disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric properties. Am J Gastroenterol. 2010;105:2085-2092.
32. Szigethy E, Thompson R, Turner S, et al. Cognitive behavioral therapy for general medical conditions. In: E S, Weisz JR, Findling RL, eds. Cognitive Behavioral Therapy for Children and Adolescents. Washington, DC: American Psychiatric Publishing; 2012:331-382.
33. Eisenberger NI, Berkman ET, Inagaki TK, et al. Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry. 2010;68:748-754.
34. Stata Statistical Software: Release 12 [Computer Program]. College Station, TX: StataCorp LP; 2011.
35. Goodhand JR, Wahed M, Mawdsley JE, et al. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis. 2012.
36. Szigethy EM, Youk AO, Benhayon D, et al. Depression subtypes in pediatric inflammatory bowel disease. J Pediatric Gastroenterology Nutrition. 2014;58:574-581.
37. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65:732-741.
38. Franzen PL, Buysse DJ, Rabinovitz M, et al. Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment. Psychiatry Res. 2010;177: 240-245.
39. Spirito A, Esposito-Smythers C, Wolff J, et al. Cognitive-behavioral therapy for adolescent depression and suicidality. Child Adolesc Psychiatr Clin N Am. 2011;20:191-204.
40. Raison CL, Rutherford RE, Woolwine BJ, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatmentresistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70:31-41.
41. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, et al. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology. 2006;131:1122-1130.
42. Ghia JE, Blennerhassett P, Collins SM. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest. 2008;118:2209-2218.
43. Koopman FA, Stoof SP, Straub RH, et al. Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol Med. 2011;17:937-948.
44. Ghia JE, Blennerhassett P, El-Sharkawy RT, et al. The protective effect of the vagus nerve in a murine model of chronic relapsing colitis. Am J Physiol Gastrointest Liver Physiol. 2007;293:G711-G718.
45. Mawdsley J, Jenkins D, Macey M, et al. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol. 2008;103:1460-1469.
46. Rosenkranz MA, Davidson RJ, Maccoon DG, et al. A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation. Brain Behav Immun. 2013;27:174-184.
47. Schoen M, Nowack K. Reconditioning the stress response with hypnosis CD reduces the inflammatory cytokine IL-6 and influences resilience: a pilot study. Complement Ther Clin Pract. 2013;19:83-88.
48. Rahimi HR, Shiri M, Razmi A. Antidepressants can treat inflammatory bowel disease through regulation of the nuclear factor-kappaB/nitric oxide pathway and inhibition of cytokine production: a hypothesis. World J Gastrointest Pharmacol Ther. 2012;3:83-85.
49. Daneshmand A, Mohammadi H, Rahimian R, et al. Chronic lithium administration ameliorates 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in rats; potential role for adenosine triphosphate sensitive potassium channels. J Gastroenterol Hepatol. 26:1174-1181.
50. Brustolim D, Ribeiro-dos-Santos R, Kast RE, et al. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol. 2006;6:903-907.
51. Kane S, Altschuler EL, Kast RE. Crohn's disease remission on bupropion. Gastroenterology. 2003;125:1290.
52. Kast R. Anti-and pro-inflammatory considerations in antidepressant use during medical illness: bupropion lowers and mirtazapine increases circulating tumor necrosis factor-alpha levels. Gen Hosp Psychiatry. 2003;25: 495-496.
53. Felger JC, Miller AH. Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol. 2012;33:315-327.
54. Miller AH, Haroon E, Raison CL, et al. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety. 2013;30: 297-306.
55. Feise RJ. Do multiple outcome measures require p-value adjustment? BMC Med Res Methodol. 2002;2:8.